- Age stratified histopathological spectrum of endometrial samples.
| Endometrial sample reports | <40 years (n=690) | 40-55 years (n=4466) | > 55 years (n=1302) | Total (N=6458) |
|---|---|---|---|---|
| Unsatisfactory | 91 (13.2) | 625 (14.0) | 186 (14.3) | 902 (14.0) |
| Proliferative phase | 99 (14.4) | 685 (15.3) | 56 (4.3) | 840 (13.0) |
| Secretory phase | 180 (26.1) | 760 (17.0) | 28 (2.2) | 968 (15.0) |
| Menstrual endometrium | 3 (0.4) | 33 (0.7) | 4 (0.3) | 40 (0.6) |
| Atrophic | 3 (0.4) | 322 (7.2) | 387 (29.8) | 712 (11.0) |
| Luteal phase defect | 17 (2.5) | 25 (0.6) | 3 (0.2) | 45 (0.7) |
| Effects of exogenous hormone therapy | 17 (2.5) | 144 (3.2) | 30 (2.3) | 191 (3.0) |
| Disordered proliferative endometrium | 60 (8.7) | 674 (15.1) | 77 (5.9) | 811 (12.6) |
| Chronic endometritis | 39 (5.7) | 242 (5.4) | 28 (2.2) | 309 (4.8) |
| Endometrial polyp | 153 (22.2) | 739 (16.6) | 285 (21.9) | 1177 (18.3) |
| Simple hyperplasia without atypia | 18 (2.6) | 152 (3.4) | 84 (6.5) | 254 (3.9) |
| Simple hyperplasia with atypia | 2 (0.3) | 10 (0.2) | 8 (0.6) | 20 (0.3) |
| Complex hyperplasia without atypia | 5 (0.7) | 6 (0.1) | 13 (1.0) | 24 (0.4) |
| Complex hyperplasia with atypia | 1 (0.1) | 20 (0.5) | 22 (1.7) | 43 (0.7) |
| Malignancy | 2 (0.3) | 29 (0.7) | 91 (7.0) | 122 (1.9) |
| TOTAL | 690 (100) | 4466 (100) | 1302 (100) | 6458 (100) |
Values are presented as number and percentage (%)